BioRestorative Therapies Inc. (NASDAQ: BRTX)
$1.77
N/A ( 0% ) 11.0K
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
Market Data
Open
$1.77
Previous close
$1.77
Volume
11.0K
Market cap
$12.02M
Day range
$1.78 - $1.87
52 week range
$1.03 - $3.67
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | Feb 05, 2024 |
8-k | 8K-related | 17 | Feb 01, 2024 |
4 | Insider transactions | 1 | Dec 05, 2023 |
4 | Insider transactions | 1 | Dec 01, 2023 |
10-q | Quarterly Reports | 52 | Nov 13, 2023 |
4 | Insider transactions | 1 | Sep 18, 2023 |
4 | Insider transactions | 1 | Sep 18, 2023 |
8-k | 8K-related | 12 | Sep 15, 2023 |
4 | Insider transactions | 1 | Sep 14, 2023 |
4 | Insider transactions | 1 | Sep 13, 2023 |